McLean-based RxAnte, developing technologies that help make sure people take their prescription drugs, has received a $4.6 million investment from Aberdare Ventures and West Health Investment.
The company will use the financing to continue development of its technologies and take them to market.
{iframe}http://www.bizjournals.com/washington/news/2012/09/12/rxante-gets-46m-investment.html?ana=e_du_pap&s=article_du&ed=2012-09-12{/iframe}